Αρχική World News New targeted treatments raise the bar in immunotherapy-resistant melanoma World News New targeted treatments raise the bar in immunotherapy-resistant melanoma Από Ogkologos - 27 Οκτωβρίου, 2026 96 0 Facebook Twitter Google+ Pinterest WhatsApp Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR FDA Approves Nogapendekin Alfa Inbakicept-pmln for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer 26 Απριλίου, 2024 Women Experience More Side Effects from Pelvic Radiation than Realized 8 Απριλίου, 2020 Additional Translations of the ESMO Patient Guides Now Available in the Croatian 18 Μαΐου, 2026 Born Blind With 50% Chance Of Survival, 20-Year-Old Musician Defied All... 1 Νοεμβρίου, 2021 Φόρτωση περισσοτέρων HOT NEWS To My Fellow Nurses Quantitative Summary of QoL Data Confirms Immune Checkpoint Inhibitor Therapy Is... Plans for NCI’s Fiscal Year 2019 Budget Brain Cancer Cells Hijack Gene “On Switches” to Drive Tumor Growth